NasdaqGS:IARTMedical Equipment
Integra LifeSciences Holdings (IART) Quarterly Losses Challenge Bullish Margin Recovery Narrative
Integra LifeSciences Holdings (IART) has wrapped up FY 2025 with fourth quarter revenue of US$434.9 million and a basic EPS loss of US$0.02, alongside trailing 12 month revenue of US$1.6 billion and a basic EPS loss of US$6.74. Over recent quarters the company has seen revenue move between US$380.8 million and US$442.6 million while quarterly basic EPS has ranged from a loss of US$6.31 to a profit of US$0.25. This has set up a results season where investors are weighing growth potential...